« USPTO - It's Quality over Quantity | Main | Remicade Update - Hurry Up and Wait until 2011 »

10/14/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b01348832fae7970c

Listed below are links to weblogs that reference Termeer out $11 M @ $69 per share - Buddy can you spare a dime? :

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Account Deleted

Wow, that puts a whole different perspective on why Genzyme and Termeer were being so intransigent over the $69/share offer.

Conflict of interest? No much!

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada